We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

15 hedge funds and large institutions have $7.12M invested in Tempest Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0.28% less ownership

Funds ownership: 2.62% → 2.34% (-0.28%)

12% less funds holding

Funds holding: 17 → 15 (-2)

43% less capital invested

Capital invested by funds: $12.4M → $7.12M (-$5.29M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$35.3K
2
IC
Ikarian Capital
Texas
+$10.6K
3
Franklin Resources
Franklin Resources
California
+$1.95K
4
Morgan Stanley
Morgan Stanley
New York
+$953
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$590

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$622K
2
MS
Maven Securities
Jersey
-$409K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$147K
4
Millennium Management
Millennium Management
New York
-$77K
5
Renaissance Technologies
Renaissance Technologies
New York
-$35.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
RSCM
1
Rock Springs Capital Management
Maryland
$2.78M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2.2M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$842K -$147K -3,247 -14%
Fidelity International
4
Fidelity International
Bermuda
$441K – – –
BlackRock
5
BlackRock
New York
$280K – – –
IC
6
Ikarian Capital
Texas
$210K +$10.6K +233 +5%
Renaissance Technologies
7
Renaissance Technologies
New York
$136K -$35.7K -787 -20%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$117K +$590 +13 +0.5%
Franklin Resources
9
Franklin Resources
California
$54K +$1.95K +43 +4%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$34K +$35.3K +777 New
TRCT
11
Tower Research Capital (TRC)
New York
$7K -$2K -44 -21%
Morgan Stanley
12
Morgan Stanley
New York
$7K +$953 +21 +15%
Bank of America
13
Bank of America
North Carolina
$3K – – –
NMC
14
NEA Management Company
Maryland
– -$622K -9,060 Closed
MS
15
Maven Securities
Jersey
– -$409K -5,952 Closed
Millennium Management
16
Millennium Management
New York
– -$77K -1,125 Closed
Group One Trading
17
Group One Trading
Illinois
– -$1K -15 Closed
JP Morgan Chase
18
JP Morgan Chase
New York
– +$454 +10 New

TPST Hedge Fund Activity: Q1 2022 in Review

15 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2022, worth a combined $7.12M — down 43% from $12.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TPST and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was Two Sigma Advisers, opening a new position worth an estimated $35.3K. The largest seller was NEA Management Company, exiting entirely with an estimated $622K sold.

  • 15 institutional investors held Tempest Therapeutics (TPST) as of Q1 2022, down from 17 in Q4 2021.
  • Funds reported $7.12M of Tempest Therapeutics stock for Q1 2022, down 43% quarter-over-quarter.
  • 2 funds opened new Tempest Therapeutics positions in Q1 2022 and 4 closed out, a net change of -2 holders.
  • The largest Tempest Therapeutics buyer in Q1 2022 was Two Sigma Advisers, an estimated $35.3K added.
  • The largest Tempest Therapeutics seller in Q1 2022 was NEA Management Company, an estimated $622K sold.

Based on aggregated 13F filings for Q1 2022.